Jiao Hu

1.9k total citations · 1 hit paper
56 papers, 1.1k citations indexed

About

Jiao Hu is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jiao Hu has authored 56 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Surgery, 22 papers in Pulmonary and Respiratory Medicine and 19 papers in Molecular Biology. Recurrent topics in Jiao Hu's work include Bladder and Urothelial Cancer Treatments (26 papers), Ferroptosis and cancer prognosis (16 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Jiao Hu is often cited by papers focused on Bladder and Urothelial Cancer Treatments (26 papers), Ferroptosis and cancer prognosis (16 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Jiao Hu collaborates with scholars based in China, United States and Germany. Jiao Hu's co-authors include Xiongbing Zu, Jinbo Chen, Huihuang Li, Belaydi Othmane, Anze Yu, Wenbiao Ren, Peihua Liu, Minfeng Chen, Zhenglin Yi and Dongxu Qiu and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Biochemical and Biophysical Research Communications.

In The Last Decade

Jiao Hu

52 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer

2021 250 citations Jiao Hu, Anze Yu et al. Theranostics profile →

Peers

Countries citing papers authored by Jiao Hu

Since Specialization

Citations

This map shows the geographic impact of Jiao Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiao Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiao Hu more than expected).

Fields of papers citing papers by Jiao Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiao Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiao Hu. The network helps show where Jiao Hu may publish in the future.

Co-authorship network of co-authors of Jiao Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiao Hu. A scholar is included among the top collaborators of Jiao Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiao Hu. Jiao Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dynamic remodeling of tertiary lymphoid structures in response to cancer therapy: a recent review 2025 ·Cancer Immunology Immunotherapy ·Changming Tan, Jinliang Huang, Ning Gao, Bingquan Wu, (unknown), (unknown), Jiao Hu, Ping Liu, Jinbo Chen	0
2	Application of ChatGPT-assisted problem-based learning teaching method in clinical medical education 2025 ·BMC Medical Education ·(unknown), Zewu Zhu, Jiao Hu, Yu Cui	16
3	Neutrophil-mediated alteration of CXCL1/IL-8/AR signaling promotes prostate cancer cell proliferation 2025 ·Experimental Cell Research ·(unknown), (unknown), (unknown), Zhen Li, (unknown), (unknown), Jiao Hu, Yuanwei Li, Xiongbing Zu, (unknown)	1
4	Overcoming immunotherapy resistance in bladder cancer with a novel antibody-drug conjugate RC48 2025 ·Journal for ImmunoTherapy of Cancer ·(unknown), Jinhui Liu, Chunyu Zhang, (unknown), Zhenyu Nie, Zhenglin Yi, Xin Gao, (unknown), Jinliang Huang, Zhiyong Cai, (unknown), Bingquan Wu, (unknown), Jinbo Chen, (unknown), Jiao Hu	0
5	Microsurgical varicocelectomy and revascularization: a novel approach to varicocele treatment 2025 ·Current Problems in Surgery ·Jinhui Liu, (unknown), (unknown), Jian Ding, Ning Gao, (unknown), Bin Huang, (unknown), Jiao Hu, Jinbo Chen, Zicheng Xiao, Weimin Zhou, Xiongbing Zu, Peihua Liu	0
6	Nanotherapeutic System with Effective Microwave Sensitization and Pyroptosis Programming Enable Synergistic Microwave-Immunotherapy in Bladder Cancer 2024 ·Biomaterials Research ·Hao Deng, Jinliang Huang, Ning Gao, Zhi Liu, Zhenglin Yi, (unknown), (unknown), Chunyu Zhang, (unknown), Jiao Hu, Jinbo Chen, (unknown)	0
7	Metabolic Syndrome and the Risk of Kidney Stones: Evidence from 487 860 UK Biobank Participants 2024 ·The Journal of Clinical Endocrinology & Metabolism ·Minghui Liu, Meng Gao, (unknown), Zewu Zhu, Jiao Hu, Hequn Chen, (unknown), Jinbo Chen	12
8	Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8⁺ T cell infiltration and functional transition 2023 ·Journal for ImmunoTherapy of Cancer ·Anze Yu, Jiao Hu, Liangmin Fu, (unknown), (unknown), Mingxiao Zhang, Yinghan Wang, Guannan Shu, (unknown), Huihuang Li, Xu Chen, Taowei Yang, Jinhuan Wei, Zhenhua Chen, Xiongbing Zu, Junhang Luo	14
9	S100A5 Attenuates Efficiency of Anti‐PD‐L1/PD‐1 Immunotherapy by Inhibiting CD8⁺ T Cell‐Mediated Anti‐Cancer Immunity in Bladder Carcinoma 2023 ·Advanced Science ·Huihuang Li, Jinbo Chen, Zhenghao Li, Minfeng Chen, Zhenyu Ou, Miao Mo, Ruizhe Wang, Shiyu Tong, Peihua Liu, Zhiyong Cai, Chunyu Zhang, Zhi Liu, (unknown), Jinhui Liu, (unknown), Jiao Hu, Xiongbing Zu	32
10	Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma 2022 ·Frontiers in Immunology ·Zhiyong Cai, (unknown), (unknown), Jiao Hu, (unknown), Xiongbing Zu, Zhenghao Li, Huihuang Li	24
11	TNF Family–Based Signature Predicts Prognosis, Tumor Microenvironment, and Molecular Subtypes in Bladder Carcinoma 2022 ·Frontiers in Cell and Developmental Biology ·Huihuang Li, Siyuan Liu, (unknown), (unknown), Jiao Hu, Cheng Zhao	14
12	m⁶A-induced lncDBET promotes the malignant progression of bladder cancer through FABP5-mediated lipid metabolism 2022 ·Theranostics ·Peihua Liu, (unknown), Belaydi Othmane, Jiao Hu, Huihuang Li, Yu Cui, Zhenyu Ou, Jinbo Chen, Xiongbing Zu	51
13	5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer 2021 ·BMC Medicine ·Jiao Hu, Belaydi Othmane, Anze Yu, Huihuang Li, Zhiyong Cai, Xu Chen, Wenbiao Ren, Jinbo Chen, Xiongbing Zu	52
14	LncRNA SNHG9 is a prognostic biomarker and correlated with immune infiltrates in prostate cancer 2021 ·Translational Andrology and Urology ·Chao Li, Jiao Hu, Xiheng Hu, Cheng Zhao, Miao Mo, Xiongbing Zu, Yangle Li	27
15	Efficacy of Intra-Arterial Plus Intravesical Chemotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer: A Pooled Analysis 2021 ·Frontiers in Pharmacology ·(unknown), Dongxu Qiu, Jinbo Chen, Xiongbing Zu, Jinhui Liu, Huihuang Li, Jiao Hu, Zhenglin Yi, (unknown), Zhi Chen, Yu Cui	1
16	Adjuvant chemotherapy in patients with locally advanced bladder cancer after neoadjuvant chemotherapy and radical cystectomy: a systematic review and pooled analysis 2021 ·Translational Andrology and Urology ·Zhiyong Cai, Hang Jin, Jinbo Chen, Jiao Hu, Huihuang Li, Zhenglin Yi, Xiongbing Zu	7
17	Intracorporeal versus extracorporeal urinary diversion after robot‐assisted radical cystectomy: a pooled analysis 2021 ·Gland Surgery ·Zhiyong Cai, Huihuang Li, Jiao Hu, Dongxu Qiu, Zhenglin Yi, Jinbo Chen, Xiongbing Zu	6
18	A comprehensive evaluation of differentially expressed mRNAs and lncRNAs in cystitis glandularis with gene ontology, KEGG pathway, and ceRNA network analysis 2020 ·Translational Andrology and Urology ·Chao Li, Jiao Hu, Peihua Liu, Qiaqia Li, Jinbo Chen, Yu Cui, Xu Zhou, (unknown), Xin Zhang, Xin Gao, Xiongbing Zu	2
19	ISYNA1 is overexpressed in bladder carcinoma and regulates cell proliferation and apoptosis 2019 ·Biochemical and Biophysical Research Communications ·(unknown), Huihuang Li, Jiao Hu, (unknown), (unknown), (unknown), Peihua Liu, Yu Cui, Longfei Liu, Minfeng Chen, Jinbo Chen, Xiongbing Zu	10
20	Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients 2018 ·Medicine ·Jiao Hu, (unknown), Yu Cui, (unknown), Wenbiao Ren, (unknown), Longfei Liu, Hequn Chen, Xiongbing Zu	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact